These findings are consistent with previous reports showing that tumor-infiltrating ILC2s highly express PD-1 in malignant melanomas [25], as well as in a pancreatic carcinoma model [33]. The gene discussed is PDCD1; the disease is exocrine pancreatic carcinoma.